nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Vandetanib—thyroid cancer	0.272	0.367	CbGbCtD
Atazanavir—ABCC1—Epirubicin—thyroid cancer	0.187	0.253	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—thyroid cancer	0.0995	0.134	CbGbCtD
Atazanavir—CYP2C9—Sorafenib—thyroid cancer	0.0408	0.0551	CbGbCtD
Atazanavir—ABCB1—Sorafenib—thyroid cancer	0.0396	0.0534	CbGbCtD
Atazanavir—CYP3A4—Vandetanib—thyroid cancer	0.0393	0.0531	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—thyroid cancer	0.024	0.0324	CbGbCtD
Atazanavir—CYP3A4—Sorafenib—thyroid cancer	0.0237	0.032	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—thyroid cancer	0.0144	0.0194	CbGbCtD
Atazanavir—Ecchymosis—Epirubicin—thyroid cancer	0.00041	0.00158	CcSEcCtD
Atazanavir—Mouth ulceration—Epirubicin—thyroid cancer	0.00041	0.00158	CcSEcCtD
Atazanavir—Rash—Vandetanib—thyroid cancer	0.000409	0.00158	CcSEcCtD
Atazanavir—Dermatitis—Vandetanib—thyroid cancer	0.000409	0.00158	CcSEcCtD
Atazanavir—Headache—Vandetanib—thyroid cancer	0.000407	0.00157	CcSEcCtD
Atazanavir—Colitis—Doxorubicin—thyroid cancer	0.000403	0.00155	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000399	0.00154	CcSEcCtD
Atazanavir—Fluid retention—Doxorubicin—thyroid cancer	0.000399	0.00154	CcSEcCtD
Atazanavir—Dyspnoea—Sorafenib—thyroid cancer	0.000391	0.0015	CcSEcCtD
Atazanavir—Nausea—Vandetanib—thyroid cancer	0.000386	0.00149	CcSEcCtD
Atazanavir—Dyspepsia—Sorafenib—thyroid cancer	0.000386	0.00149	CcSEcCtD
Atazanavir—Oesophagitis—Doxorubicin—thyroid cancer	0.000384	0.00148	CcSEcCtD
Atazanavir—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000382	0.00147	CcSEcCtD
Atazanavir—Decreased appetite—Sorafenib—thyroid cancer	0.000381	0.00147	CcSEcCtD
Atazanavir—Ecchymosis—Doxorubicin—thyroid cancer	0.00038	0.00146	CcSEcCtD
Atazanavir—Mouth ulceration—Doxorubicin—thyroid cancer	0.00038	0.00146	CcSEcCtD
Atazanavir—Diabetes mellitus—Epirubicin—thyroid cancer	0.000379	0.00146	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000378	0.00146	CcSEcCtD
Atazanavir—Fatigue—Sorafenib—thyroid cancer	0.000378	0.00145	CcSEcCtD
Atazanavir—Photosensitivity—Epirubicin—thyroid cancer	0.000375	0.00144	CcSEcCtD
Atazanavir—Pain—Sorafenib—thyroid cancer	0.000375	0.00144	CcSEcCtD
Atazanavir—Constipation—Sorafenib—thyroid cancer	0.000375	0.00144	CcSEcCtD
Atazanavir—Vascular purpura—Epirubicin—thyroid cancer	0.000368	0.00142	CcSEcCtD
Atazanavir—Eczema—Epirubicin—thyroid cancer	0.000367	0.00141	CcSEcCtD
Atazanavir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000358	0.00138	CcSEcCtD
Atazanavir—Increased appetite—Epirubicin—thyroid cancer	0.000351	0.00135	CcSEcCtD
Atazanavir—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00035	0.00135	CcSEcCtD
Atazanavir—Urticaria—Sorafenib—thyroid cancer	0.000348	0.00134	CcSEcCtD
Atazanavir—Photosensitivity—Doxorubicin—thyroid cancer	0.000347	0.00134	CcSEcCtD
Atazanavir—Body temperature increased—Sorafenib—thyroid cancer	0.000346	0.00133	CcSEcCtD
Atazanavir—Abdominal pain—Sorafenib—thyroid cancer	0.000346	0.00133	CcSEcCtD
Atazanavir—Dermatitis bullous—Epirubicin—thyroid cancer	0.000345	0.00133	CcSEcCtD
Atazanavir—Purpura—Epirubicin—thyroid cancer	0.000342	0.00132	CcSEcCtD
Atazanavir—Vascular purpura—Doxorubicin—thyroid cancer	0.000341	0.00131	CcSEcCtD
Atazanavir—Eczema—Doxorubicin—thyroid cancer	0.000339	0.00131	CcSEcCtD
Atazanavir—Hypoglycaemia—Epirubicin—thyroid cancer	0.000338	0.0013	CcSEcCtD
Atazanavir—Pain in extremity—Epirubicin—thyroid cancer	0.000329	0.00127	CcSEcCtD
Atazanavir—Increased appetite—Doxorubicin—thyroid cancer	0.000324	0.00125	CcSEcCtD
Atazanavir—Affect lability—Epirubicin—thyroid cancer	0.000324	0.00125	CcSEcCtD
Atazanavir—Hypersensitivity—Sorafenib—thyroid cancer	0.000323	0.00124	CcSEcCtD
Atazanavir—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000319	0.00123	CcSEcCtD
Atazanavir—Purpura—Doxorubicin—thyroid cancer	0.000316	0.00122	CcSEcCtD
Atazanavir—Asthenia—Sorafenib—thyroid cancer	0.000314	0.00121	CcSEcCtD
Atazanavir—Cardiac arrest—Epirubicin—thyroid cancer	0.000313	0.00121	CcSEcCtD
Atazanavir—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000312	0.0012	CcSEcCtD
Atazanavir—Mood swings—Epirubicin—thyroid cancer	0.000312	0.0012	CcSEcCtD
Atazanavir—Pruritus—Sorafenib—thyroid cancer	0.00031	0.00119	CcSEcCtD
Atazanavir—Dehydration—Epirubicin—thyroid cancer	0.000306	0.00118	CcSEcCtD
Atazanavir—Pain in extremity—Doxorubicin—thyroid cancer	0.000305	0.00117	CcSEcCtD
Atazanavir—Dry skin—Epirubicin—thyroid cancer	0.000302	0.00116	CcSEcCtD
Atazanavir—Affect lability—Doxorubicin—thyroid cancer	0.0003	0.00116	CcSEcCtD
Atazanavir—Diarrhoea—Sorafenib—thyroid cancer	0.0003	0.00115	CcSEcCtD
Atazanavir—Breast disorder—Epirubicin—thyroid cancer	0.000298	0.00115	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000297	0.00114	CcSEcCtD
Atazanavir—Nasopharyngitis—Epirubicin—thyroid cancer	0.000295	0.00113	CcSEcCtD
Atazanavir—Gastritis—Epirubicin—thyroid cancer	0.000292	0.00112	CcSEcCtD
Atazanavir—Muscular weakness—Epirubicin—thyroid cancer	0.000291	0.00112	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000291	0.00112	CcSEcCtD
Atazanavir—Cardiac arrest—Doxorubicin—thyroid cancer	0.00029	0.00112	CcSEcCtD
Atazanavir—Dizziness—Sorafenib—thyroid cancer	0.00029	0.00112	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—thyroid cancer	0.000289	0.00111	CcSEcCtD
Atazanavir—Abdominal distension—Epirubicin—thyroid cancer	0.000287	0.0011	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—thyroid cancer	0.000283	0.00109	CcSEcCtD
Atazanavir—Eosinophilia—Epirubicin—thyroid cancer	0.000282	0.00109	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—thyroid cancer	0.000279	0.00108	CcSEcCtD
Atazanavir—Pancreatitis—Epirubicin—thyroid cancer	0.000279	0.00108	CcSEcCtD
Atazanavir—Vomiting—Sorafenib—thyroid cancer	0.000279	0.00107	CcSEcCtD
Atazanavir—Rash—Sorafenib—thyroid cancer	0.000276	0.00106	CcSEcCtD
Atazanavir—Dermatitis—Sorafenib—thyroid cancer	0.000276	0.00106	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—thyroid cancer	0.000275	0.00106	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000274	0.00106	CcSEcCtD
Atazanavir—Headache—Sorafenib—thyroid cancer	0.000274	0.00106	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000273	0.00105	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—thyroid cancer	0.00027	0.00104	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000269	0.00104	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—thyroid cancer	0.000269	0.00104	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—thyroid cancer	0.000266	0.00103	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—thyroid cancer	0.000265	0.00102	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—thyroid cancer	0.000263	0.00101	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—thyroid cancer	0.000261	0.001	CcSEcCtD
Atazanavir—Nausea—Sorafenib—thyroid cancer	0.00026	0.001	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00026	0.001	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—thyroid cancer	0.000259	0.000998	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—thyroid cancer	0.000258	0.000995	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—thyroid cancer	0.000258	0.000992	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000257	0.000989	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000252	0.000969	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—thyroid cancer	0.00025	0.000961	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000249	0.000958	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—thyroid cancer	0.000247	0.000953	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—thyroid cancer	0.000247	0.000953	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—thyroid cancer	0.000247	0.00095	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—thyroid cancer	0.000246	0.000949	CcSEcCtD
Atazanavir—Sweating—Epirubicin—thyroid cancer	0.000243	0.000937	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—thyroid cancer	0.000243	0.000937	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—thyroid cancer	0.000242	0.000932	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00024	0.000926	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00024	0.000925	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—thyroid cancer	0.00024	0.000923	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—thyroid cancer	0.000238	0.000918	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000238	0.000915	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000233	0.000897	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—thyroid cancer	0.000231	0.000889	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00023	0.000887	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—thyroid cancer	0.000229	0.000882	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—thyroid cancer	0.000229	0.000882	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—thyroid cancer	0.000228	0.000879	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—thyroid cancer	0.000228	0.000878	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—thyroid cancer	0.000227	0.000873	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—thyroid cancer	0.000225	0.000867	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—thyroid cancer	0.000225	0.000867	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—thyroid cancer	0.000225	0.000865	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—thyroid cancer	0.000224	0.000863	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—thyroid cancer	0.000224	0.000863	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—thyroid cancer	0.000223	0.00086	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000222	0.000856	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—thyroid cancer	0.000215	0.00083	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—thyroid cancer	0.000213	0.00082	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—thyroid cancer	0.000212	0.000818	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—thyroid cancer	0.000212	0.000815	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—thyroid cancer	0.000211	0.000812	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00021	0.000808	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000208	0.000802	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—thyroid cancer	0.000208	0.0008	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000207	0.000798	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—thyroid cancer	0.000207	0.000796	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—thyroid cancer	0.000207	0.000796	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—thyroid cancer	0.000206	0.000793	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—thyroid cancer	0.000205	0.000791	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—thyroid cancer	0.000201	0.000776	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—thyroid cancer	0.0002	0.000769	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000199	0.000768	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—thyroid cancer	0.000198	0.000764	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—thyroid cancer	0.000197	0.000759	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—thyroid cancer	0.000197	0.000757	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—thyroid cancer	0.000196	0.000754	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—thyroid cancer	0.000195	0.000753	CcSEcCtD
Atazanavir—Tension—Epirubicin—thyroid cancer	0.000195	0.00075	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—thyroid cancer	0.000194	0.000748	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—thyroid cancer	0.000193	0.000742	CcSEcCtD
Atazanavir—Back pain—Epirubicin—thyroid cancer	0.000192	0.000739	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—thyroid cancer	0.000191	0.000737	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—thyroid cancer	0.00019	0.000734	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00019	0.000732	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—thyroid cancer	0.000186	0.000718	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—thyroid cancer	0.000185	0.000712	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—thyroid cancer	0.000184	0.000709	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—thyroid cancer	0.000184	0.000707	CcSEcCtD
Atazanavir—Agitation—Epirubicin—thyroid cancer	0.000182	0.000702	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—thyroid cancer	0.000181	0.000697	CcSEcCtD
Atazanavir—Tension—Doxorubicin—thyroid cancer	0.00018	0.000694	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—thyroid cancer	0.00018	0.000692	CcSEcCtD
Atazanavir—Malaise—Epirubicin—thyroid cancer	0.000179	0.000689	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—thyroid cancer	0.000178	0.000687	CcSEcCtD
Atazanavir—Syncope—Epirubicin—thyroid cancer	0.000178	0.000685	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—thyroid cancer	0.000178	0.000684	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—thyroid cancer	0.000175	0.000675	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—thyroid cancer	0.000174	0.000672	CcSEcCtD
Atazanavir—Cough—Epirubicin—thyroid cancer	0.000173	0.000667	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—thyroid cancer	0.000172	0.000662	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—thyroid cancer	0.000171	0.00066	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00017	0.000656	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—thyroid cancer	0.000168	0.000648	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000168	0.000646	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—thyroid cancer	0.000167	0.000643	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—thyroid cancer	0.000166	0.000638	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—thyroid cancer	0.000165	0.000636	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—thyroid cancer	0.000165	0.000634	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—thyroid cancer	0.000163	0.000629	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—thyroid cancer	0.000162	0.000625	CcSEcCtD
Atazanavir—Oedema—Epirubicin—thyroid cancer	0.000162	0.000624	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—thyroid cancer	0.000161	0.000621	CcSEcCtD
Atazanavir—Infection—Epirubicin—thyroid cancer	0.000161	0.00062	CcSEcCtD
Atazanavir—Cough—Doxorubicin—thyroid cancer	0.00016	0.000617	CcSEcCtD
Atazanavir—Shock—Epirubicin—thyroid cancer	0.000159	0.000614	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—thyroid cancer	0.000159	0.000613	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—thyroid cancer	0.000159	0.000612	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—thyroid cancer	0.000158	0.00061	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—thyroid cancer	0.000157	0.000606	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—thyroid cancer	0.000157	0.000603	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—thyroid cancer	0.000156	0.000602	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—thyroid cancer	0.000156	0.000602	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—thyroid cancer	0.000156	0.000602	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—thyroid cancer	0.000156	0.0006	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000155	0.000598	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—thyroid cancer	0.000154	0.000595	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—thyroid cancer	0.000154	0.000594	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—thyroid cancer	0.000153	0.000589	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—thyroid cancer	0.000151	0.000582	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—thyroid cancer	0.00015	0.000577	CcSEcCtD
Atazanavir—Infection—Doxorubicin—thyroid cancer	0.000149	0.000573	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000148	0.000568	CcSEcCtD
Atazanavir—Shock—Doxorubicin—thyroid cancer	0.000147	0.000568	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000147	0.000566	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—thyroid cancer	0.000146	0.000564	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—thyroid cancer	0.000146	0.00056	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000145	0.000558	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—thyroid cancer	0.000144	0.000556	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—thyroid cancer	0.000144	0.000554	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—thyroid cancer	0.000143	0.00055	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—thyroid cancer	0.000143	0.000549	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—thyroid cancer	0.000141	0.000542	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00014	0.000538	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—thyroid cancer	0.00014	0.000538	CcSEcCtD
Atazanavir—Pain—Epirubicin—thyroid cancer	0.000138	0.000533	CcSEcCtD
Atazanavir—Constipation—Epirubicin—thyroid cancer	0.000138	0.000533	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000136	0.000526	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—thyroid cancer	0.000135	0.000522	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—thyroid cancer	0.000134	0.000514	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—thyroid cancer	0.000133	0.000514	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—thyroid cancer	0.000133	0.000513	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000132	0.00051	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—thyroid cancer	0.000132	0.000508	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—thyroid cancer	0.00013	0.000502	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000129	0.000498	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—thyroid cancer	0.000129	0.000497	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—thyroid cancer	0.000129	0.000495	CcSEcCtD
Atazanavir—Pain—Doxorubicin—thyroid cancer	0.000128	0.000493	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—thyroid cancer	0.000128	0.000493	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—thyroid cancer	0.000128	0.000493	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—thyroid cancer	0.000128	0.000493	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—thyroid cancer	0.000123	0.000475	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000123	0.000472	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—thyroid cancer	0.000119	0.000459	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—thyroid cancer	0.000119	0.000458	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—thyroid cancer	0.000118	0.000456	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—thyroid cancer	0.000118	0.000456	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—thyroid cancer	0.000116	0.000447	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—thyroid cancer	0.000115	0.000441	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—thyroid cancer	0.000111	0.000427	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—thyroid cancer	0.00011	0.000425	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—thyroid cancer	0.000107	0.000414	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—thyroid cancer	0.000107	0.000412	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—thyroid cancer	0.000106	0.000408	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—thyroid cancer	0.000103	0.000396	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—thyroid cancer	0.000103	0.000395	CcSEcCtD
Atazanavir—Rash—Epirubicin—thyroid cancer	0.000102	0.000393	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—thyroid cancer	0.000102	0.000393	CcSEcCtD
Atazanavir—Headache—Epirubicin—thyroid cancer	0.000101	0.000391	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—thyroid cancer	9.91e-05	0.000382	CcSEcCtD
Atazanavir—Nausea—Epirubicin—thyroid cancer	9.62e-05	0.00037	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—thyroid cancer	9.53e-05	0.000367	CcSEcCtD
Atazanavir—Rash—Doxorubicin—thyroid cancer	9.45e-05	0.000364	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—thyroid cancer	9.44e-05	0.000363	CcSEcCtD
Atazanavir—Headache—Doxorubicin—thyroid cancer	9.39e-05	0.000361	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—thyroid cancer	8.9e-05	0.000343	CcSEcCtD
